Research
My research examines the impact of health and social policies on health care access, health outcomes, and health disparities, with a focus on low-income women, pregnant people, and families. I typically draw on observational and quasi-experimental methods to derive policy insights from large datasets, including population surveys, vital statistics, and administrative claims. This page highlights some of the past and ongoing themes of my research agenda. For an updated list of my publications, please see my Google Scholar page.
Postpartum Assessment of Health Survey (PAHS)
More than one-half of pregnancy-related deaths occur in the “fourth trimester” or year after birth. Major policy efforts, such as postpartum Medicaid extensions, are currently underway to improve health outcomes and health equity for postpartum people. To inform evidence-based policy and public health programming, I am leading the first multi-state data collection effort on postpartum health and social wellbeing. This project is conducted in collaboration with seven states and New York City and funded by Columbia World Projects and the National Institutes on Minority Health and Health Disparities. The 2020 PAHS data collection is complete and the 2024 PAHS data collection will launch in January 2025.. Learn more about the survey here.
Select Publications:
Daw JR, Underhill K, Liu C, Allen HL. 2023. The health and social needs of Medicaid beneficiaries in the postpartum year: evidence from a multistate survey. Health Affairs 42(11): 1575-85.
Ongoing Projects:
The Postpartum Assessment of Health Survey (PAHS): Informing Medicaid Policies to Improve Health in the "Fourth Trimester" (NIMHD R01MD017460; PIs: Daw JR & Allen HL)
Insurance Coverage and Access to Care for Reproductive-Age and Pregnant Women
Insurance coverage is critical for ensuring that women have access to preventive care, including but not limited to the period surrounding pregnancy. This body of work focuses on characterizing the patterns of health insurance coverage for reproductive-age women in the U.S. and evaluating the impacts of the Affordable Care Act on women and children.
Select Publications:
Daw JR, McCallum-Bridges CL, Kozhimannil KB, Admon LK. 2024. Continuous Medicaid eligibility during the COVID-19 pandemic and postpartum coverage, health care, and outcomes. JAMA Health Forum 5(3): e240004.
Gordon SH, Hoagland A, Admon LK, Daw JR. 2022. Extended postpartum coverage is associated with improve coverage continuity in the postpartum year. Health Affairs 31(1).
Daw JR, Winkelman TNA, Dalton VK, Kozhimannil KB, Admon LA. 2020. Medicaid expansion improved perinatal insurance continuity for low-income women. Health Affairs 39(9): 1531-1539.
Daw JR, Kolenic GE, Zivin K, Winkelman TNA, Dalton VK, Kozhimannil KB, Admon LA. 2020. Racial and ethnic disparities in perinatal insurance. Obstetrics & Gynecology 135(4): 1-8.
Daw JR, Hatfield LA, Swartz K, Sommers BD. 2017. Women in the United States experience high rates of insurance coverage ‘churn’ in months before and after childbirth. Health Affairs 36(4): 598-606.
Daw JR, Sommers BD. 2018. Association of the Affordable Care Act dependent coverage provision with prenatal care use and birth outcomes. JAMA 319(6): 579-587.
Ongoing Projects:
Improving Maternal and Child Health in the Year After Birth: An Early Evaluation of Postpartum Medicaid Eligibility Extensions (AHRQ R01; MPIs: Daw JR & Admon LK)
Improving Methods and Data for Health Policy Evaluation
Knowing what policies and programs work to improve health - and which don't - is critical for allocating scarce resources. This body of work aims to reduce uncertainty around common challenges in health policy evaluation and contribute to the development of 'gold standard' observational methods. This theme also includes methodological contributions on best practices for using existing administrative and claims data to study questions in maternal health.
Select Publications:
Bellerose M, Daw JR, Steenland MW. 2023. Differences in self-reported and billed postpartum visits among Medicaid-insured women in South Carolina. JAMA Network Open 6(12): e2349457.
Auty SG, Daw JR, Admon LK, Gordon SH. 2023. Comparing approaches to identify live births using the Transformed Medicaid Statistical Information System Files. Health Services Research 59(1): e14233.
Daw JR, Howell EA. 2023. Defining goals and investing in data to advance postpartum health and health equity. JAMA Network Open 6(6): e2316542.
Daw JR, Auty SG, Admon LK, Gordon SH. 2023. Using modernized Medicaid data to advance evidence-based improvements in maternal health. American Journal of Public Health 113(7): 705-824.
Daw JR, Hatfield LA. 2018. Matching and Regression-to-the-Mean in Difference-in-Differences Analysis. Health Services Research 53(6), Part I: 4138-4156
Daw JR, Hatfield LA. 2018. Matching in Difference-in-Differences: Between a Rock and a Hard Place. Health Services Research 53(6), Part I: 4111-4117.
Ongoing Projects:
Advancing differences-in-differences methods for unpoolable data (Canadian Institutes for Health Research; PI: Strumpf E)
Prescription Drug Coverage and Pricing Policy
Prescription drugs represent a large and growing proportion of health care costs in the U.S. and other developed countries. My research on pharmaceutical policy focuses on (1) evaluating the impact of prescription drug coverage and pricing policies on access and costs, and (2) studying how prescription drug coverage policies develop, especially in relation to existing social programs.
Much of this work focuses on Canada, a country with a prescription drug coverage policy that is unique in the world: Canada is the only country with a universal health insurance scheme that excludes prescription medicines.
Select Publications:
Daw JR, Law MR. 2020. Compared with other countries, women in the U.S. are more likely than men to forgo medicines because of cost. Health Affairs, 39(8): 1334-1342.
Daw JR, Morgan SG, Collins PA, Abelson J. 2014. Framing incremental expansions to public health insurance programs: the case of Canadian pharmacare. Journal of Health Politics, Policy, and Law 39(2): 295-330.
Morgan SG, Law MR, Daw JR, Abraham L, Martin D. 2015. Estimated cost of universal public coverage of prescription drugs in Canada. Canadian Medical Association Journal 187: 491-497.